Annual report pursuant to Section 13 and 15(d)

SEGMENT REPORTING - Net Sales and Segment Profit (Details)

v3.23.1
SEGMENT REPORTING - Net Sales and Segment Profit (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]    
Revenue, net $ 17,800,000 $ 15,374,000
Gross profit 4,330,000 6,809,000
Non-cash share based compensation (2,343,000) (11,451,000)
Depreciation and amortization (2,059,000) (1,768,000)
Goodwill impairment 0 (18,508,000)
Loss from operations (75,102,000) (57,207,000)
Loss (gain) on debt extinguishment, net 2,263,000 (3,262,000)
Gain on remeasurement of warrant liability (2,092,000) (16,856,000)
Gain on investments (6,851,000) 0
Foreign exchange loss 1,129,000 1,276,000
Interest expense 2,702,000 6,818,000
Other expense (income), net 202,000 (502,000)
Loss from operations before income taxes and equity investment loss (72,455,000) (44,681,000)
Cannabinoid    
Segment Reporting Information [Line Items]    
Goodwill impairment 0 (18,508,000)
Non-Cannabinoid    
Segment Reporting Information [Line Items]    
Goodwill impairment 0 0
Operating Segments    
Segment Reporting Information [Line Items]    
Revenue, net 17,800,000 15,374,000
Gross profit (62,374,000) (14,284,000)
Operating Segments | Cannabinoid    
Segment Reporting Information [Line Items]    
Revenue, net 6,119,000 3,242,000
Gross profit (63,720,000) (16,915,000)
Operating Segments | Non-Cannabinoid    
Segment Reporting Information [Line Items]    
Revenue, net 11,681,000 12,132,000
Gross profit 1,346,000 2,631,000
Other    
Segment Reporting Information [Line Items]    
Unallocated corporate expenses (8,327,000) (11,196,000)
Non-cash share based compensation (2,343,000) (11,451,000)
Depreciation and amortization (2,058,000) (1,768,000)
Goodwill impairment 0 (18,508,000)
Loss from operations $ (75,102,000) $ (57,207,000)